You are here
BRIDGENE BIOSCIENCES INC
Company Information
Information
UEI: N/A
# of Employees: 7
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia
Amount: $298,928.00PROJECT SUMMARY Acute myeloid leukemia (AML), a malignant disease of hematopoietic precursor cells in the bone marrow, is one of the most common cancers in adults accounting for 1% of all cancers. AML ...
STTRPhase I2020Department of Health and Human Services National Institutes of Health -
A Novel Chemical Proteomics Platform to Expand Druggable Space
Amount: $223,000.00Abstract A bottleneck in drug discovery is the lack of high quality small molecule probes to validate the disease relevance of genesparticularly those with promising disease linkage but are considered ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health